Autoimmune Liver Diseases and Rheumatoid Arthritis-Is There an Etiopathogenic Link?

autoimmune hepatitis autoimmune liver diseases primary biliary cirrhosis primary sclerosing cholangitis rheumatoid arthritis

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Mar 2024
Historique:
received: 07 02 2024
revised: 28 02 2024
accepted: 23 03 2024
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 13 4 2024
Statut: epublish

Résumé

Rheumatoid arthritis (RA) is a systemic immune-mediated disease that, in addition to the articular involvement, can have extra-articular manifestations. Even though liver damage in RA is not very common, associated autoimmune liver diseases (AILDs) may occur. The most common AILD associated with RA is primary biliary cirrhosis (PBC), followed by autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC). There are common underlying mechanisms that play a role in the emergence of autoimmunity and inflammation in both rheumatic and autoimmune liver diseases. Genetic studies have revealed the existence of several common disease-associated genes shared between RA and AILDs, and infectious triggers, particularly those associated with recurrent or complicated urinary tract infections, are also speculated to be potential triggers for these conditions. Moreover, these diseases share common serologic patterns characterized by the presence of specific autoantibodies and hyper-gammaglobulinemia. In this study, we focus on reviewing the association between RA and AILDs regarding the prevalence and possible etiopathogenic link.

Identifiants

pubmed: 38612658
pii: ijms25073848
doi: 10.3390/ijms25073848
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ioana Ruxandra Mihai (IR)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Ciprian Rezus (C)

Department of Internal Medicine, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
"Sfantul Spiridon" Emergency Hospital, 700111 Iasi, Romania.

Maria Alexandra Burlui (MA)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Anca Cardoneanu (A)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Luana Andreea Macovei (LA)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Patricia Richter (P)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Ioana Bratoiu (I)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Elena Rezus (E)

Department of Rheumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Clinical Rehabilitation Hospital, 700661 Iasi, Romania.

Classifications MeSH